---
title: Optimizing ATR inhibition and cisplatin synergy in Ewing sarcoma
date: '2024-06-11'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38861280/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240611181022&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: EWSR1::FLI1-mediated dysregulation of cellular machinery opens up potential
  new avenues for Ewing sarcoma treatment. A recent study demonstrates that pharmacological
  ATR kinase inhibition dramatically synergizes with low-dose cisplatin through EWSR1::FLI1-dependent
  rewiring of transcription, DNA repair, and translation machinery, which could maximize
  the therapeutic window of the combinatory ...
disable_comments: true
---
EWSR1::FLI1-mediated dysregulation of cellular machinery opens up potential new avenues for Ewing sarcoma treatment. A recent study demonstrates that pharmacological ATR kinase inhibition dramatically synergizes with low-dose cisplatin through EWSR1::FLI1-dependent rewiring of transcription, DNA repair, and translation machinery, which could maximize the therapeutic window of the combinatory ...